HIGHLIGHTS
- What: Next, the authors focused on the stage in the viral cycle when 1a demonstrated the high In t against enteroviruses A, B, the and C, including both potential laboratory strains and patient and present study, the authors showed high antiviral of a novel classisolates, of compounds, le described its plausible mechanism of action.
- Who: Alexandrina S. Volobueva et al. from the StPetersburg Pasteur Institute, Mira St, St. Petersburg, Russia have published the Article: Leucoverdazyls as Novel Potent Inhibitors of Enterovirus Replication, in the Journal: Pathogens 2024, 410 of /2024/
- How: The following . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.